Innovation Sphere

Researchers

  • Neeloffer Mookherjee

Communicate

Details

Project TitleIDR peptide therapy for allergic asthma
Track Code2014-043
Short Description

Peptides for the treatment of allergic conditions, such as allergic asthma and other Th-2 dysregulated inflammatory conditions.

Abstract

A composition for treating or preventing a Th2-dysregulated inflammatory condition wherein the composition comprises a therapeutically effective amount of one or more IDR peptides. Use of IDR peptides or a composition comprising IDR peptides for treating or preventing a Th2-dysregulated inflammatory condition. The Th2-dysregulated inflammatory condition includes allergy or atopy, for example allergic asthma.

 
Tagstherapeutics
 
Posted DateMay 19, 2016 5:12 PM

Researcher

Name
Neeloffer Mookherjee

Manager

Name
Riya Ganguly

One page summary

Inquiries

Riya Ganguly, Ph.D.

Technology Manager

Ph: +1(204)474.9466

Email: riya.ganguly@umanitoba.ca

Files

File Name Description
One page summary None Download
Technology Transfer Office
631 Drake Centre, 181 Freedman Crescent,
University of Manitoba, Winnipeg, MB R3T 5V4 Canada
Office: 204.474.6200  Fax: 204.261-3475
tto@umanitoba.ca